Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $6,500 per benefit period · Income ≤500% FPL, adjusted for household size and high-cost living areas · Prescription drug copayments or Medicare Part B insurance premiums for Myelodysplastic Syndromes treatments.
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
C92.00 C92.01 D46.0 D46.1 D46.2 D46.20 D46.21 D46.22 D46.4 D46.9 D46.A D46.B D46.C D46.ZDrugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J0894 J9025
The foundation's own covered-medication list for this fund (3 drugs). Confirm coverage of your exact NDC at application.
Run a Medicare estimate for a covered drug in about a minute. The fund's award caps against the patient share CareCost calculates.
As of June 10, 2026, the HealthWell Foundation Myelodysplastic Syndromes - Medicare Access fund is OPEN and accepting applications. Verify at time of service: 800-675-8416.
Up to $6,500 per benefit period. Prescription drug copayments or Medicare Part B insurance premiums for Myelodysplastic Syndromes treatments.
Household income must be ≤500% FPL, adjusted for household size and high-cost living areas. Treatment must occur in the United States.
Accepted: medicare.